(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 13.36% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 57.29%.
Radnet's revenue in 2026 is $1,969,599,000.On average, 11 Wall Street analysts forecast RDNT's revenue for 2026 to be $176,510,830,496, with the lowest RDNT revenue forecast at $157,764,269,390, and the highest RDNT revenue forecast at $189,394,269,610. On average, 8 Wall Street analysts forecast RDNT's revenue for 2027 to be $193,251,586,710, with the lowest RDNT revenue forecast at $165,710,342,616, and the highest RDNT revenue forecast at $206,983,635,586.
In 2028, RDNT is forecast to generate $216,781,221,020 in revenue, with the lowest revenue forecast at $203,203,464,828 and the highest revenue forecast at $228,507,465,004.